Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in recurrent hepatocellular carcinoma therapy
Yuxue Gao, Qi-Qi Ning, Pengxiang Yang, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 460-476
Open Access | Times Cited: 16

Showing 16 citing articles:

A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis
Zijie Wu, Zehua Dong, Jiangti Luo, et al.
Genomics (2024) Vol. 116, Iss. 3, pp. 110831-110831
Open Access | Times Cited: 7
How Do I Diagnose Fibrolamellar Carcinoma?
Haukur Einarsson, Rondell P. Graham
Modern Pathology (2025), pp. 100711-100711
Closed Access
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
Panagiota Maravelia, Hongyang Yao, Curtis Cai, et al.
Gut (2025), pp. gutjnl-334148
Closed Access
Machine learning-based integration reveals immunological heterogeneity and the clinical potential of T cell receptor (TCR) gene pattern in hepatocellular carcinoma
Zewei Zhuo, Huihuan Wu, Lingli Xu, et al.
APOPTOSIS (2025)
Closed Access
Pro-inflammatory Mediator and Cancer-Associated Chemokine CXCL8 as a Prognostic Indicator of Tumor Aggressiveness, Angiogenesis, and Disease Progression with Focus on Therapeutic Implications and Recurrence Monitoring
Hema Shree. K, Gayathri Rengasamy, Vishnu Priya Veeraraghavan, et al.
Oral Oncology Reports (2025), pp. 100723-100723
Open Access
Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine
Abhimati Ravikulan, Kamran Rostami
World Journal of Gastroenterology (2024) Vol. 30, Iss. 5, pp. 424-428
Open Access | Times Cited: 3
Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report
Yonggang He, Zheng Wang, Jing Li, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 11, pp. 4506-4513
Closed Access | Times Cited: 2
Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma
Lien‐Hung Huang, Shao‐Chun Wu, Yueh‐Wei Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11969-11969
Open Access | Times Cited: 1
ROBOTIC VERSUS LAPAROSCOPIC REPEAT HEPATECTOMY: A COMPARATIVE SINGLE-CENTER STUDY OF PERIOPERATIVE OUTCOMES
S. Vancoillie, E. Willems, Céline De Meyere, et al.
European Journal of Surgical Oncology (2024) Vol. 51, Iss. 1, pp. 109376-109376
Closed Access | Times Cited: 1
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-PD1 Antibody for Inhibiting Recurrence of Hepatitis B-related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results
Albert Qin, Chang‐Ru Wu, Ming‐Chih Ho, et al.
(2023)
Open Access | Times Cited: 3
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results
Albert Qin, Chang‐Ru Wu, Ming‐Chih Ho, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 433-433
Open Access | Times Cited: 3
Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept
Mohamed Wishahi
World Journal of Hepatology (2024) Vol. 16, Iss. 4, pp. 490-493
Open Access
The liver sinusoid at single-cell level
Ravi Parhar, Prakash Ramachandran
Elsevier eBooks (2024), pp. 111-133
Closed Access
An Overview of the Deubiquitinase USP53: A Promising Diagnostic Marker and Therapeutic Target
Guangce Xia, Yulin Guo, Jiajia Zhang, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 9, pp. 708-718
Open Access
The Combined Use of Dickkopf-1 and Soluble Axl Improves Hepatocellular Carcinoma Diagnostic Efficacy in Hepatitis C Patients
Ereny Samuell, Abdel-Aziz Abdel-Aziz, Ahmed Shehata, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 6, pp. 2185-2191
Open Access
Hepatocellular carcinoma‑cavernous hemangioma collision tumor: A case report
Shiheng Wu, Xinxing Zhang, Bao Jin, et al.
Oncology Letters (2023) Vol. 27, Iss. 2
Open Access
Page 1

Scroll to top